Press releaseGlobe Newswire
Gyre Therapeutics
GYRE · NASDAQ
$6.17+$0.08 (+1.31%)TodayMarket closed ·
Prev close $6.09
Latest news
- Press releaseGlobe Newswire
Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment
- Press releaseGlobe Newswire
Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update
- Press releaseGlobe Newswire
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
- Press releaseGlobe Newswire
Gyre Therapeutics Announces China's NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment
- News
Earnings Scheduled For March 12, 2026
- News
Gyre Therapeutics Q4 Adj. EPS $0.05 Misses $0.06 Estimate, Sales $37.195M Beat $36.303M Estimate
- Press releaseGlobe Newswire
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline
- NewsAvi Kapoor
Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday
- Press releaseGlobe Newswire
Gyre Therapeutics Announces Alignment with China's CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting
- News
Earnings Scheduled For November 7, 2025
- News
Gyre Therapeutics Q3 EPS $0.03 Beats $(0.02) Estimate, Sales $30.600M Miss $32.930M Estimate
- Press releaseGlobe Newswire
Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis
- NewsVandana Singh
Gyre Therapeutics Gains Attention As Under-The-Radar Liver Fibrosis Drug Maker
- NewsAvi Kapoor
MAC Copper, ATS, Pony AI And Other Big Stocks Moving Higher On Tuesday
- NewsAvi Kapoor
Ross Stores, Deckers Outdoor, Xerox Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.